Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

SELL
$31.71 - $43.0 $15,252 - $20,683
-481 Reduced 96.39%
18 $1,000
Q1 2022

May 11, 2022

BUY
$29.88 - $37.04 $149 - $185
5 Added 1.01%
499 $18,000
Q4 2021

Jan 10, 2022

SELL
$25.61 - $35.1 $9,322 - $12,776
-364 Reduced 42.42%
494 $15,000
Q3 2021

Nov 24, 2021

BUY
$33.54 - $40.55 $4,695 - $5,677
140 Added 19.5%
858 $29,000
Q2 2021

Jul 30, 2021

BUY
$34.54 - $47.25 $6,528 - $8,930
189 Added 35.73%
718 $29,000
Q1 2021

Apr 29, 2021

BUY
$42.51 - $63.78 $22,487 - $33,739
529 New
529 $24,000
Q4 2020

Jan 15, 2021

SELL
$45.3 - $60.27 $271 - $361
-6 Closed
0 $0
Q2 2020

Jul 10, 2020

BUY
$46.85 - $61.05 $281 - $366
6 New
6 $0

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.